Earlier this week, Chemical & Engineering News featured a wonderful look into the important role that animal research, specifically that with canine models, play in improving human and veterinary help. The article, “Could Fido Fetch a Cure?” takes a close look at dogs with cancer and the valuable insight they are providing to help cure the disease.
After receiving the diagnosis that Moses, a six-year-old black Labrador retriever, had lymphoma, he was enrolled by his family in a clinical trial at the University of Missouri where he would be treated with new class of chemotherapy drugs. These new agents, called indenoisoquinolines, were developed through a collaboration between the United States’ top veterinary schools and the National Institutes of Health’s (NIH) Comparative Oncology Trials Consortium (COTC). The article notes, “running clinical trials on dogs with cancer is a win-win. Trials may save the lives of beloved family pets, while the data collected can be used to inform drug development for human patients.” Thanks to their efforts, Moses is doing well.
Cancer is not exclusively a human problem and our four-legged friends are helping researchers improve therapy. To learn more about this effort, please read “Could Fido Catch a Cure?” by clicking here.